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Abstract 
Network biology is a rapidly developing area of biomedical research and reflects the current view that complex phe-
notypes, such as disease susceptibility, are not the result of single gene mutations that act in isolation but are rather 
due to the perturbation of a gene’s network context. Understanding the topology of these molecular interaction net-
works and identifying the molecules that play central roles in their structure and regulation is a key to understanding 
complex systems. The falling cost of next-generation sequencing is now enabling researchers to routinely catalogue 
the molecular components of these networks at a genome-wide scale and over a large number of different condi-
tions. In this review, we describe how to use publicly available bioinformatics tools to integrate genome-wide ‘omics’ 
data into a network of experimentally-supported molecular interactions. In addition, we describe how to visualize and 
analyze these networks to identify topological features of likely functional relevance, including network hubs, bot-
tlenecks and modules. We show that network biology provides a powerful conceptual approach to integrate and find 
patterns in genome-wide genomic data but we also discuss the limitations and caveats of these methods, of which 
researchers adopting these methods must remain aware.
© 2016 Charitou et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Cellular processes are controlled and coordinated at mul-
tiple levels by tightly regulated transcriptional, post-tran-
scriptional and post-translational molecular networks. 
Recent advances and falling costs of technologies such as 
next-generation sequencing (NGS) and mass spectrom-
etry (MS) are enabling researchers to catalogue the com-
ponent molecules of these networks at a genome-wide 
scale and under a large number of different experimen-
tal conditions (e.g. time points, cell types, stimuli and 
treatments). These high-throughput approaches typically 
result in one or more lists of genes or proteins (or other 
molecules such as lipids or metabolites) that are signifi-
cantly altered, in their expression for example, at a spe-
cific time-point or condition. However, without further 
analysis, such lists are often of relatively limited use and 
fail to reveal the complex inter-relationships that may 
exist between molecules, their coordinated functions, 
and the emergent properties of the system. In this review, 
we discuss how researchers can move from gene lists to 
more systems-oriented analyses of their data, with a par-
ticular focus on using experimentally-supported molecu-
lar interaction networks. We discuss how to use publicly 
available bioinformatics tools and molecular interaction 
data to construct a network from a gene/protein list and 
explore how to subsequently visualize and analyze these 
networks for the purpose of revealing new insights into 
the phenotype of interest at the systems’ level. We give 
examples of how such approaches are being applied in the 
literature and we will focus particularly on examples of 
relevance to the animal functional genomics community.
Gene ontology and pathway analysis
As discussed above, the initial output of most genome-
wide ‘omics’ experiments is a list of genes (or their 
products) that are significantly altered in the condition 
of interest. Typically, the first step in the investigation 
of these datasets is a functional enrichment analysis, 
which determines whether the list of genes is statistically 
enriched for certain biological processes or functions. 
The Gene Ontology (GO) consortium, for example, pro-
vides a controlled hierarchical vocabulary of terms for 
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describing genes and their encoded products in terms 
of their molecular functions, biological processes or cel-
lular components [1]. A GO enrichment analysis can be 
undertaken using one of the many publicly available tools 
(http://geneontology.org/page/go-enrichment-analysis) 
and these analyses examine the gene list for the occur-
rence of GO terms that are more prevalent in the query 
gene list than expected by chance (it is important to 
note that using an appropriate background or ‘universe’ 
to assess statistical significance is essential) [2]. Such 
over-represented terms may highlight previously unrec-
ognised biological processes (as opposed to individual 
genes) that are preferentially and differentially regulated 
in the condition of interest. A feature of GO that is both 
a strength and a limitation is its hierarchical structure. 
Although efforts have been made to account for this 
structure in GO enrichment analyses [3], it can still be 
difficult to determine which level of the hierarchy is most 
responsible for the statistical enrichment. Often the most 
enriched terms are broad functional categories which can 
be of limited use to inform new functional insight.
In cells, biological pathways are the biochemical 
engines that are responsible for the transduction of sig-
nals (often received by receptors) into output responses 
(e.g. activation of a transcription factor and downstream 
gene expression). An enrichment analysis based on path-
way annotations can therefore contain information that 
is more directly relevant and interpretable regarding the 
important processes at play in a particular condition. A 
wide variety of pathway analysis methods are available 
[4], including over-representation methods such as those 
implemented in KEGG [5], Reactome [6], WikiPathways 
[7, 8], InnateDB [9], or DAVID [10]; more quantitative 
methods based on gene set enrichment [11]; and more 
recent methods that attempt to account for the fact that 
not all genes have the same power to distinguish between 
different pathways [12].
Although powerful, pathway analysis methods also 
have their limitations. First, the majority of genes have 
not been assigned to a canonical pathway (e.g., more 
than 85  % of human Ensembl genes are not mapped to 
any KEGG pathway), and second, for those that are, there 
is a heavy bias towards well-studied signalling pathways 
[13]. Thus, pathway analysis can tell us a lot about what 
we already know but less about new and unexpected rela-
tionships between genes of interest or indeed between 
the pathways themselves.
Network analysis
Network biology is a rapidly developing area of research, 
which recognises that biological processes are not 
chiefly controlled by individual proteins or by discrete, 
unconnected linear pathways, but rather by a complex 
system-level network of molecular interactions [14]. 
Understanding how these molecular interaction net-
works give rise to emergent biological processes and 
identifying the important nodes and other topological 
features, which are key to controlling them, are crucial 
to understanding complex phenotypes in health and 
disease. Network medicine theory also proposes that 
disease-associated phenotypes are not the result of sin-
gle gene mutations acting in isolation but are rather due 
to the perturbation of a gene’s network context [15]. 
Therefore, the elucidation of disease mechanisms and 
the development of effective therapeutic targets require 
a deep understanding of how molecular interaction net-
works are pathogenically dysregulated. In practice, net-
work analysis can also be an extremely powerful and 
complementary approach to traditional enrichment anal-
ysis methods [16]. Advantages of this approach include 
the fact that network-based analyses are both more data 
driven and also less constrained by the limits of current 
functional annotations, as proteome-scale maps of the 
interactome (the complete complement of molecular 
interactions within a biological system) are now available 
for several species, including humans [17]. Because of 
this, network analyses are less biased towards well-stud-
ied pathways and have a far greater coverage of known 
genes and proteins.
The interactome may be intuitively represented and 
interpreted by constructing a graph or network, in 
which an entity (e.g. gene, transcript, protein, miRNA, or 
metabolite) is represented by a node and its relationships 
or interactions to other entities by a series of pairwise 
lines or edges between these nodes. Networks are not 
restricted to one type of entity (node type) or relationship 
(edge type) and are often used to visualize and interpret 
several types of molecules and their molecular relation-
ships simultaneously (physical interaction, reaction, 
regulation, correlation, etc.). This allows a more com-
plete and realistic representation of a biological system. 
Additional information associated with the nodes (e.g. 
gene expression data) or edges (e.g. a confidence score) 
can also be easily integrated via the use of node and edge 
attributes. Another advantage is that network/graph 
theory and supporting computational methods are well 
established in other domains, which has allowed for the 
rapid re-purposing and development of software to sup-
port network visualization and analysis in biology [18].
There are two broad approaches that one can adopt 
when performing network analysis on a gene list of inter-
est. The first is to overlay the genome-wide ‘omics’ data 
(e.g. gene expression data) on a pre-established global 
network of experimentally-supported interactions (e.g. 
public protein–protein interactions (PPI)), while the sec-
ond is to infer a network directly from the data generated 
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in the experiment (for a review of these approaches see 
[19]). In this review, we focus largely on the former inte-
grative method and discuss both the strengths and limi-
tations of this approach.
Constructing a molecular interaction network 
from a list of genes
The first consideration when constructing a molecular 
interaction network from publicly available data is what 
type of interaction data one wants to include in the net-
work and where to source that data. A sometimes con-
fusing plethora of molecular interaction databases are 
publicly available [20]. Researchers need to be aware that 
not all of these databases contain the same type or qual-
ity of interaction data. Some databases, such as those that 
are members of the International Molecular Exchange 
(IMEx) Consortium [21], promote painstaking manual 
curation of experimentally-validated interaction data 
directly from the peer-reviewed biomedical literature. 
Other so-called ‘meta’-databases integrate and repack-
age interaction data from these primary sources and 
make it available through a single portal. Some databases 
also supplement experimentally-validated interaction 
information with computationally-predicted interac-
tions [22]. Although this practice is useful for enriching 
a sparse experimental interaction network, users need 
to be more aware of this. We also suggest that research-
ers compare results that are generated using an experi-
mentally-validated network versus the network that has 
been supplemented with computationally-predicted 
edges. Researchers should also note that primary inter-
action databases show limited overlap in the interac-
tion information they provide. This is partly intentional, 
as developers of the IMEx databases take steps to avoid 
duplication of effort in their very labour-intensive manual 
curation processes. However, this also means, that a lot 
of additional well-supported public interaction informa-
tion will be ignored if interactions are sourced from one 
database only. Fortunately, web-services, such as PSIC-
QUIC [23], are available to enable researchers to query 
multiple databases simultaneously, although, to date, the 
majority of papers reporting network analyses have not 
been so comprehensive.
Once all the experimentally-validated interactions that 
involve a given gene list (or their products) have been 
retrieved, there are some additional points to consider 
before proceeding to the downstream network analysis. 
First, the experimentally-validated interactions retrieved 
may be of several types, including physical (e.g. PPI or 
protein-DNA), regulatory (e.g. microRNA-mRNA), 
or biochemical interactions (e.g. phosphorylations). 
Although it may be valuable to integrate many types of 
interactions, one must proceed with caution since the 
meaning of an edge in such a network will vary substan-
tially and this needs to be taken into account during sub-
sequent analyses of the data. Physical PPI, for example, 
are usually undirected edges and may capture informa-
tion regarding protein complexes, whereas biochemical 
interactions are usually directed (e.g. A phosphorylates 
B) and relate to a flow of signal information. Another 
consideration in the case of physical protein interactions 
that are determined by affinity purification coupled with 
mass spectrometry (AP-MS) [24], is that these methods 
usually cannot distinguish between direct and indirect 
interactors, although they are often represented as direct 
binary interactions in networks that are constructed 
using publicly available tools.
Another important consideration is the level of con-
fidence associated with a particular molecular interac-
tion, which may vary considerably, depending on how 
that interaction was experimentally determined. On the 
one hand, high-throughput approaches such as Yeast 
2-Hybrid (Y2H), can be used to generate large amounts 
of data on the interactome, which are, however, often 
associated with relatively high false positive and false 
negative rates [25]. On the other hand, interactions that 
are curated from more focused low-throughput studies 
described in the biomedical literature may have greater 
confidence but they can be biased towards well-studied 
pathways and biological processes. Several metrics have 
now been developed to provide an interaction confidence 
score and these scores can be reflected in networks using 
edge weights [26].
Finally, one must also bear in mind that the interactome 
retrieved from databases is a static snapshot of all known 
possible interactions for the given query list. Many of 
these interactions will be context-specific (e.g. occurring 
in a particular cell-type, or under specific conditions; or 
for a particular isoform of a protein [27]). Unfortunately, 
there is relatively little high-throughput context-specific 
interactome data in the literature and, thus, in molecu-
lar interaction databases. If analyses were restricted only 
to interactions that were context-specific (e.g. identified 
in the same cell-type), most of the data would be dis-
carded. However, researchers can integrate other forms 
of external contextual information, such as gene or pro-
tein expression data, to select the most likely contextual 
sub-network of nodes and edges.
Case study: constructing an 
experimentally‑validated molecular interaction 
network using InnateDB.com
A limitation of using the PSICQUIC web-service to 
build an interaction network is that it is not particularly 
accessible for most biologists. Fortunately, there are sev-
eral more user-friendly web-based platforms available. 
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Here, we provide a case study that describes how to 
use tools available at InnateDB.com to build and visu-
alize a network of experimentally-validated molecular 
interactions from a gene list [9, 13]. InnateDB is a com-
prehensive database that contains more than 300,000 
experimentally-validated human, mouse and bovine 
molecular interactions and more than 3000 pathway 
annotations, integrated from major public molecular 
interaction and pathway databases. In addition to this 
integrated data, the InnateDB curation team has con-
textually annotated more than 25,000 innate immunity-
relevant molecular interactions through their review 
of more than 5000 biomedical articles. Interactions in 
InnateDB are curated to MIMIx standards [28] with rich 
contextual annotations, including the supporting publi-
cation, participant molecules, species, interaction detec-
tion method, host system, interaction type, cell, cell-line 
and tissue types, etc., that are associated with each inter-
action. For more details on InnateDB curation of the 
innate immunity interactome, see [29]. InnateDB is also 
an analysis platform that offers seamlessly-integrated, 
user-friendly bioinformatics tools, including pathway 
and ontology analysis, network visualization and analysis, 
and the ability to upload and analyze user-supplied gene 
expression data (or other forms of quantitative data) in a 
network and/or pathway context.
It is important to emphasise that InnateDB does not 
only contain interactions of relevance to innate immu-
nity but, as mentioned above, is also a repository for the 
entire human and mouse interactomes. The bovine inter-
actome is inferred largely via orthology with human and 
mouse genes. The limitations of using orthology to infer 
interlogs is discussed in some detail in [13], but there are 
few options for researchers working on agriculturally-
relevant animal species for which little or no experimen-
tally-validated interactome data is available. It should be 
noted that the same issues are shared with GO and path-
way analyses, as these species-specific annotations have 
also been largely inferred by orthology. Researchers who 
work on other mammalian species must map (by orthol-
ogy) gene identifiers from their species of interest to their 
corresponding human/mouse gene ID prior to using 
InnateDB. It is generally not recommended to attempt 
to infer interlogs from more evolutionarily-distant spe-
cies, since these interactions are much less likely to be 
conserved.
How to build a network using InnateDB.com
Figure  1 outlines how to upload a list of genes (or pro-
teins) and associated quantitative data (e.g. gene expres-
sion data) to InnateDB and build, visualize and analyze 
the molecular interaction network in which these genes 
(or their encoded products) participate. In this case study, 
we used a list of 514 genes from Lawless et al. [30] that 
were found to be significantly up-regulated more than 
threefold in monocytes isolated from milk at either 36 or 
48 h post infection (hpi) with the pathogen Streptococcus 
uberis, which causes mastitis (See Additional file 1: Table 
S1). Bovine gene ID were mapped to human Ensembl 
gene ID based on predicted 1:1 orthology, as described 
in [30]. To perform a network analysis using InnateDB, a 
user must first go to the “Data Analysis” menu at the top 
of the homepage and select “Network Analysis”. The user 
is then directed to the “Upload Data” form, where the 
gene list can be pasted (as well as any associated quan-
titative data). Alternatively, these data may be uploaded 
via a tab-delimited text file or spreadsheet (.xls files only). 
Quantitative data associated with the genes, which may 
be measured over as many as 10 different conditions, are 
incorporated as one or more node attributes within the 
subsequent network visualization. InnateDB provides 
a number of filters to determine which interactions are 
included in the generated network. The default (“Do not 
filter the results”) will return all the interactions for which 
at least one participant in the interaction is included 
in the uploaded list of genes. This is useful to identify 
nodes in the network that were not detected in the high-
throughput experiment from which the input list of genes 
was derived, but which preferentially interact with those 
genes/proteins. In the case of a gene expression dataset, 
such nodes may represent genes that are not differentially 
regulated at the transcriptional level but are nonetheless 
critical regulators and important components of the sys-
tem under study (e.g. transcription factors that are regu-
lated at the post-translational level; genes that fall below 
the thresholds used to define differentially-expressed 
genes; or genes that are differentially expressed at a time-
point that was not surveyed). The user can also choose 
the more conservative “Only show interactions between 
uploaded molecules” option, which will return only those 
interactions for which both interaction participants 
are members of the uploaded gene list. A third option 
allows users to return only interactions of relevance to 
a selected pathway of interest. Users can also choose to 
include interactions that were predicted by orthology, or 
only those manually annotated by InnateDB. In general, 
we would recommend that, unless the dataset is only rel-
evant to innate immunity, interactions from all databases 
integrated into InnateDB should be returned. Users will 
then be presented with a table that previews the data that 
has been uploaded. After the gene ID and quantitative 
data columns have been defined, by clicking on column 
headers, the query data can be submitted to InnateDB, 
which then builds the network.
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Network visualization and download
The network generated using InnateDB can be interac-
tively visualized using a variety of different visualiza-
tion tools (Fig. 2). The InnateDB network analysis result 
page provides an embedded visualization of the network 
using the CerebralWeb application [31], which lays out 
the nodes in layers based on their subcellular localiza-
tion. Below this, a tabular text-based description of each 
interaction in the network is presented, which contains 
further links to more detailed information for each 
interaction. In addition, interaction networks may be 
visualized and analyzed in Cerebral [32], a Java webstart 
plugin for the Cytoscape network visualization software 
[33]. Networks can also be investigated via other third-
party software, including the CyOog plugin [34], which 
uses Power Graph analysis to reduce network complex-
ity, and BioLayout Express 3D 2.2 [35], which is designed 
to visualize large networks in 2D and 3D space. All 
three applications are available via the “Visualization” 
menu, which is located beneath the main embedded net-
work visualization. From here, one can also transfer the 
uploaded gene list to NetworkAnalyst [36] for further 
network analysis (see below). All networks that are con-
structed using InnateDB can be downloaded in several 
standard formats, including text-based (.tab,  .csv,  .xls), 
the simple interaction format (.sif ), Cytoscape’s XGMML 
format, and both the PSI-MI XML 2.5 and MITAB 
exchange formats [37]. We recommend downloading the 
XGMML format (http://wiki.cytoscape.org/XGMML), 
which not only contains information on the nodes and 
edges in the network, but also their associated attributes 
and information on how to graphically represent and 
lay out the network. This format can be readily imported 
into Cytoscape for further analysis and to harness the 
diverse range of third party Cytoscape Apps that are 
available.
Fig. 1 Overview of InnateDB network analysis. a Go to the “Data Analysis” menu at the top of the InnateDB.com home page and select “Network 
Analysis”. b Paste a gene list (and any associated quantitative data) into the web form or upload the data via a tab-delimited text file or Excel 
spreadsheet (.xls files only). c Select the options for the network analysis as described in the main text. d Click on the column headers to define the 
columns that contain the gene IDs and the quantitative data. e Submit the data by clicking “Next” to tell InnateDB to build the network
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Inferring biologically important properties/
features from networks
Constructing a network, while important, is only the first 
step of any network analysis. Without further investiga-
tion of network features (e.g. node degree or network 
modularity) and how these features potentially deviate 
from statistical expectation, building a network does little 
more than generate a pretty (or sometimes ugly) picture. 
Fortunately, numerous mathematical and computational 
approaches have been developed to analyze large net-
works to identify features of interest.
Network hubs
One feature that is often informative in network analysis 
is node degree (i.e. number of interactions/edges/connec-
tions that a node has). Molecular interaction networks 
generally exhibit a scale-free topology, where the degree 
distribution approximates a power law and in which most 
nodes have few edges and a small number of nodes have a 
very high degree [38]. These high degree nodes are termed 
hubs (Fig. 3). Hub nodes are topologically important to the 
network structure and are often functionally important. 
The deletion of a hub gene, for example, is more likely to 
Fig. 2 Visualizing the network. InnateDB was used to construct a network of genes that were significantly up-regulated in monocytes isolated 
from bovine milk at either 36 or 48 h post infection (hpi) with Streptococcus uberis. Only experimentally-validated interactions between genes in 
the uploaded dataset are shown. The network can be visualized using a wide variety of applications, including a CerebralWeb, b tabular format, c 
Cytoscape, d the Cerebral Java Webstart, e Biolayout, f CyOog or g NetworkAnalyst
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be lethal than the deletion of a non-hub gene (Centrality-
lethality rule) [39], although the exact reasons for this 
correlation are still being debated [40–42]. Scale-free net-
works are also more robust to random failures than more 
uniform degree distributions but are more susceptible to 
targeted attacks [43]. Indeed, hub proteins have repeat-
edly been found to be preferentially targeted by pathogens 
[44–46]. It has also been suggested that genes encoding 
hub proteins are enriched for disease genes. Several stud-
ies have shown that cancer-related genes tend to be more 
highly connected than expected [47, 48], although more 
careful consideration of the biases in PPI networks sug-
gests that this may only be the case for particular types 
of cancers [49]. Finally, because hubs participate in many 
interactions, they are more likely to be master regulators 
of signalling and transcription. For example, the hub pro-
teins uncovered in the transcriptional response networks 
in bovine macrophages differ between infections with vir-
ulent versus avirulent Mycobacterium bovis, the causative 
agent of bovine tuberculosis [50].
Network bottlenecks
The distance between two nodes in a network can be 
measured by determining the minimum number of steps 
between them [51]. Bottleneck nodes are defined as nodes 
with a high betweenness centrality (i.e. network nodes that 
have many “shortest paths” going through them) [52]. Bot-
tleneck nodes play key roles in mediating communication 
within a given network because they facilitate informa-
tion flow between modules (relatively densely connected 
sub-networks, see next section). Such nodes are therefore 
like chokepoints in the network and have been described 
as being analogous to major bridges and tunnels on a 
highway map [52]. Disruption of a bottleneck can lead to 
network “traffic” chaos, since there are few or no alterna-
tive routes around the bottleneck. Bottleneck nodes have 
been found to be more highly correlated with essentiality 
than hub nodes [53] and are also preferentially targeted 
by pathogens [44, 45]. It should be noted that the top hub 
and bottleneck nodes often tend to be very similar (Fig. 3). 
Lawless et al. [30], for example, constructed a network of 
genes that were differentially expressed in monocytes iso-
lated from milk at 36 h post-infection with S. uberis and 
showed that 85 % of the top 20 hub proteins in the net-
work were also bottleneck nodes. Thus, it can often be dif-
ficult to assess whether a node is important because it is 
highly connected or because it is a bottleneck.
Network modules
Another important feature of many molecular networks 
is that they are modular in nature and have a high com-
munity structure [54]. Genes or proteins that occur in 
Fig. 3 Network hubs and bottlenecks. a InnateDB was used to construct a network of genes that were significantly up-regulated in the Lawless 
et al. [30] dataset. Interactions between the genes in the uploaded list, as well as all their interacting partners, were included in the network. The 
network consisted of 6259 nodes and 15,137 edges (self-loops; duplicated edges; and edges involving UBC were removed). b Hub nodes were 
identified using the CytoHubba plugin in Cytoscape 2.8.2. Cytoscape was used to extract and visualize the top 10 hub nodes and their interactors. 
Hub nodes are shown in colour with gene names. Node size is proportional to degree. c CytoHubba was also used to identify bottleneck nodes in 
the network. The top 10 bottleneck nodes are shown in colour with gene names. There is considerable overlap between the top 10 hub nodes and 
the top 10 bottleneck nodes
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particular modules tend to be enriched for common 
biological functions [55]. Thus, identifying modules 
in networks can identify coordinated biological func-
tions or processes that are not well captured in estab-
lished canonical pathway annotations. Proteins that are 
involved in the same disease or in diseases with similar 
phenotypes have also been shown to preferentially inter-
act with each other in “disease modules” [15]. One can 
therefore identify network modules that are enriched in 
genes/proteins known to be associated with a disease of 
interest (Fig. 4). Other proteins in these modules, which 
are not currently known to be associated with the dis-
ease, are promising disease-associated candidate genes. 
This network module approach has now been widely 
implemented to identify disease-associated modules for 
a range of human diseases. For example, 39 % of de novo 
severe or disruptive mutations that were associated with 
autism through exome sequencing, were found to map 
to a highly interconnected β-catenin/chromatin remod-
elling module [56]. Similarly, risk factors for congenital 
heart disease have been shown to functionally converge 
in network modules that regulate heart development 
[57]. These approaches are also gaining popularity in ani-
mal genomics studies, particularly in the identification of 
functionally relevant sub-networks from gene co-expres-
sion networks [58–60].
Bioinformatics apps to identify hubs, bottlenecks 
and modules
A wide variety of bioinformatics tools to quickly identify 
network hubs and bottlenecks are available. Some exam-
ples include the aforementioned NetworkAnalyst, a tool 
to support network-based gene expression meta-analyses 
[36]. NetworkAnalyst imports a list of user-defined genes 
and associated interactions from InnateDB to calculate 
degree, betweenness centralities and functional modules 
in the network (see below for further discussion of net-
work modules). The Cytoscape platform also provides an 
ecosystem of mainly third party Apps that can be used to 
undertake these and more advanced network analyses 
[33]. One such App is cytoHubba, which can be used to 
identify hubs and bottlenecks in networks imported into 
Cytoscape [61]. This can be used in conjunction with net-
works that are generated by using InnateDB, which can 
be downloaded in XGMML format and then imported 
into Cytoscape.
A variety of computational tools have also been devel-
oped to identify modules in networks. For a comprehen-
sive review, we refer the reader to [62]. Here we introduce 
some useful tools that represent a good starting point 
for a researcher who is new to this topic. NetworkAn-
alyst also contains more advanced network analysis fea-
tures that can be used to identify potentially functionally 
relevant network modules. NetworkAnalyst uses a ran-
dom walk algorithm to identify modules of frequently 
visited nodes. It can also generate an edge weighted net-
work, in which weights are derived from quantitative 
node information, such as gene expression attributes 
[63]. Cytoscape also provides a number of user-friendly 
applications for module detection, including jActiveMod-
ules [64], which identifies connected regions of a network 
that also show significant changes in gene expression.
However, if the aim is to find disease-associated mod-
ules, other algorithms may perform better, since it was 
recently reported that disease-associated proteins do not 
reside in particularly dense local communities and that 
disease-related nodes may be better predicted using con-
nectivity significance (i.e. whether the number of connec-
tions from a candidate protein to other known disease 
“seed” proteins is greater than statistically expected by 
chance) [65]. The Disease Module Detection algorithm 
(DIAMOnD) is a new method to detect disease modules 
based on connectivity significance.
Apart from the choice of a network analysis tool, 
researchers need to be aware that the incompleteness 
of the interactome limits which disease modules can 
be detected, and that there is a minimum threshold for 
the number of known disease-associated proteins to be 
able to detect modules associated with a disease of inter-
est [66]. Finally, it should be noted that the detection of 
hubs, bottlenecks and modules is only the tip of the ice-
berg when it comes to network analyses and further anal-
yses should be driven by the research questions that are 
specific to each study.
Conclusions and further discussion
In this review, we introduce network analysis and show 
that it is a powerful tool to assist researchers in the inter-
pretation, visualisation, and analysis of genome-wide 
‘omics’ data. However, significant challenges remain to 
be addressed. Unlike mapping the genome of a species 
(although the genome can also vary considerably between 
individuals), mapping the protein interactome of a spe-
cies is something of a fallacy. The interactome is a highly 
dynamic entity that depends on the temporal, spatial, 
cellular and environmental contexts. Fortunately, with 
advances in technology, we are now moving towards an 
era of dynamic interactome studies [67]. Recently, for 
example, researchers have mapped the Hippo signalling 
pathway protein–protein interaction network in the pres-
ence and absence of inhibition by serine and threonine 
phosphatases, and revealed how changes in phosphoryla-
tion result in a significant re-wiring of the protein inter-
actions between members of this pathway [68]. Similarly, 
Jäger et al. [69] have systematically determined the physi-
cal interactions of all 18 HIV-1 proteins and polyproteins 
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with host proteins in two human cell lines (HEK293 and 
Jurkat) and showed that only about 40  % of interactions 
occurred in both cell types, which provides insight into 
just how different the interactome is likely to be in two 
different cell types. PPI networks are also likely to be sub-
stantially re-wired in diseases, with the effect of any given 
mutation rippling through the network and causing a re-
wiring of proteins that otherwise carry no defects [15]. 
Indeed, a recent study has shown that perturbation of pro-
tein–protein interactions is widespread in human genetic 
disorders [70]. Investigating thousands of missense muta-
tions, Shani et al. [70], showed that two-thirds of disease-
associated alleles perturb protein–protein interactions.
Network re-wiring in different contexts will also 
change which topological and functional network fea-
tures are important. Network re-wiring will likely have 
an impact on the top hub and bottleneck proteins, e.g. 
a hub node in a normal network may be less central in 
a disease-associated network and vice versa. Such re-
wiring may also have an impact on the set of network 
modules that are identified in a disease network or in 
another phenotype of interest. Thus, an important focus 
for network biology will be to experimentally reconstruct 
and compare networks in normal and disease conditions 
to determine network features or components that are 
specifically associated with disease [71]. An interesting 
Fig. 4 Identifying modules in a network. The jActiveModules plugin in Cytoscape 3.1.0 was also used to identify high-scoring differentially expressed 
(DE) sub-networks in the network of Fig. 3a (using parameter values: overlap threshold = 0.3; search depth = 2). The highest-scoring module identi-
fied in the network using a the gene expression data at 36 h post-infection (hpi) and b at 48 hpi, are shown. The InnateDB pathway analysis tool 
was used to identify over-represented pathways for c the 36 hpi module and d the 48 hpi module. Note that for this dataset, the top five pathways 
for the 36 and 48 hpi modules are very similar, which reflects a similar pattern of gene expression at these time-points in this dataset
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future direction here is the question of how to target dis-
ease-associated networks for destruction while preserv-
ing normal network function [72].
Similarly, it will also be of significant interest to com-
putationally model how network re-wiring may have an 
impact on how signals flow through the network and 
alter network outputs, such as the activation of differing 
transcriptional responses. Several approaches have been 
proposed to investigate how signals flow through large 
biological networks, in particular protein–protein inter-
action (PPI) networks, for which substantial amounts 
of data are publicly available [73, 74]. One promising 
approach is information flow analysis, a computational 
biology method that uses random walk algorithms to 
model how signals flow through large networks. One 
example of software that performs this type of analysis 
is ITM Probe [75], which is also available as a Cytoscape 
App [76]. In ITM Probe, the user can define source 
nodes (nodes that emit information, e.g., receptors) and 
sink nodes (target nodes that absorb information, e.g., 
transcription factors). The algorithm then models infor-
mation flow in a protein interaction network through dis-
crete time random walks, where the walker has a certain 
probability to dissipate (i.e. to leave the network) at each 
step. Edge weight and interaction direction information 
can also be used to assign higher probabilities to certain 
paths through the network than others. The more times 
random walkers pass through a node, the higher the 
information flow score for that node will be. By altering 
the network between the source and sink nodes, one can 
computationally infer the impact of network re-wiring on 
information flow in the network.
While experimentally reconstructing networks under 
different conditions is an important goal, this will remain 
costly and technically challenging for most research 
groups well into the future. Fortunately, by overlaying 
dynamic data that is more readily generated (e.g. gene 
expression data) onto experimentally-validated networks 
(e.g. PPI), one can already gain insight into which net-
work features might be preferentially associated with 
disease or another phenotype of interest. For example, a 
static map of the interactome can show some hub nodes 
with large numbers of connections. However, proteins 
have a limited number of structural interfaces with which 
to engage in direct protein–protein interactions and can-
not interact directly with so many partners at the same 
time [77]. This has led to the classification of hubs as 
either “party” hubs, which interact with most of their 
partners simultaneously, or “date” hubs, which bind their 
different partners at different times or locations [78], 
although this classification remains hotly debated [79, 
80]. Regardless of whether this is a useful classification or 
not, it is clear that if one takes multiple random lists of 
genes and builds a network, one will find that some nodes 
are always or frequently identified as hubs because they 
are highly connected in the database and not necessar-
ily because they are relevant to the condition of interest. 
Therefore, it is important for the researcher to calculate 
statistical significance based on this background expec-
tation (e.g. using a hypergeometric distribution test), in 
a manner similar to that described previously for func-
tional enrichment analysis.
In conclusion, networks provide a powerful conceptual 
approach to integrate and find patterns in genome-wide 
genomics data but researchers adopting these approaches 
need to be conscious of their limitations and caveats. In 
this review, we have mainly focused on PPI networks but 
a wide variety of other types of networks are becoming 
ever more prevalent in the scientific literature, including 
gene co-expression networks, transcriptional regulation 
networks, and metabolic networks [71, 81]. The great chal-
lenge will be to integrate these various types of networks 
into a universal network model of the cellular interactome.
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